A phase I/II study combining erlotinib and dasatinib for non-small cell lung cancer.
Gold KA, Lee JJ, Harun N, Tang X, Price J, Kawedia JD, Tran HT, Erasmus JJ, Blumenschein GR, William WN, Wistuba II, Johnson FM.
Gold KA, et al. Among authors: tran ht.
Oncologist. 2014 Oct;19(10):1040-1. doi: 10.1634/theoncologist.2014-0228. Epub 2014 Aug 28.
Oncologist. 2014.
PMID: 25170013
Free PMC article.
Clinical Trial.